Andreas Laustsen is Professor & Center Director at DTU Bioengineering. He is an expert on antibody technology, including design, discovery, and characterization. Moreover, he is specialized in toxinology and has focused much of his research on developing different types of antibodies against toxins from venomous animals and bacteria. Andreas is a co-founder of the 8 biotech companies, Biosyntia, VenomAb, Chromologics, Bactolife, Antag Therapeutics, VenomAid Diagnostics, Agrobiomics, and Combotope Therapeutics, of which 7 are thriving and employ about 120 FTEs.